Success Metrics

Clinical Success Rate

77.8%

Based on 7 completed trials

Completion Rate

78%(7/9)

Active Trials

3(25%)

Results Posted

43%(3 trials)

Terminated

2(17%)

Phase Distribution

Ph phase_4

17%

Ph phase_1

25%

Ph phase_2

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 1Safety & dosage

3(50.0%)

Phase 2Efficacy & side effects

1(16.7%)

Phase 4Post-market surveillance

2(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

77.8%

7 of 9 finished

Non-Completion Rate

22.2%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Completed(7)

Terminated(2)

Detailed Status

Completed7

Recruiting3

Terminated2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

77.8%

Most Advanced

Phase 4

Trials by Phase

Phase 13 (50.0%)

Phase 21 (16.7%)

Phase 42 (33.3%)

Trials by Status

terminated217%

completed758%

recruiting325%

Recent Activity

3 active trials

Showing 5 of 12

recruiting

Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

NCT04291612

terminatedphase_1

Clinical Trials (12)

Showing 12 of 12 trials

NCT04291612

Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

Recruiting

NCT02780128Phase 1

Next Generation Personalized Neuroblastoma Therapy

Terminated

NCT04857528

Detecting HPV DNA in Anal and Cervical Cancers

Recruiting

NCT05594693

Integrative Health Interventions in Symptom Management of Pediatric Patients

Completed

NCT04713657Phase 1

Beta-blocker Administration for Cardiomyocyte Division

Recruiting

NCT03714555Phase 2

Disulfiram-Copper Gluconate in Met Pancreas Cancer w Rising CA19-9 on Abraxane-Gemzar, FOLFIRINOX or Gemcitabine

Terminated

NCT04321538

Gocheck Kids vs. Welch Allyn Spot Vision Screener

Completed

NCT02572869

Functional and Aesthetic Outcomes After Mandible Reconstruction With Fibula Osteomyocutaneous Free Flaps

Completed

NCT02383706

Obstructive Sleep Apnea in Pregnancy

Completed

NCT00099463Phase 1

Phase I Study of a Vaccine for Severe Acute Respiratory Syndrome (SARS)

Completed

NCT00734097Phase 4

A Study of Nexium (Esomeprazole) 40 mg Once Daily in Subjects With Symptoms of Gastroesophageal Reflux Disease (GORD) After Treatment With a Full Dose of Proton Pump Inhibitor (PPI)

Completed

NCT00384592Phase 4

PPI Sequencing Study

Completed

All 12 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 12